Alliance Pharma (LON:APH) Reaches New 12-Month Low at $31.00

Alliance Pharma plc (LON:APH)’s stock price reached a new 52-week low during mid-day trading on Tuesday . The company traded as low as GBX 31 ($0.39) and last traded at GBX 32 ($0.40), with a volume of 4439000 shares changing hands. The stock had previously closed at GBX 33.10 ($0.42).

Analyst Upgrades and Downgrades

Separately, Royal Bank of Canada reduced their target price on Alliance Pharma from GBX 65 ($0.82) to GBX 60 ($0.75) and set an “outperform” rating on the stock in a report on Wednesday, January 31st.

Alliance Pharma Price Performance

The stock has a market capitalization of £172.93 million, a P/E ratio of -3,310.00, a PEG ratio of 1.04 and a beta of 0.60. The company has a current ratio of 1.93, a quick ratio of 1.42 and a debt-to-equity ratio of 45.00. The company has a fifty day simple moving average of GBX 37.59 and a two-hundred day simple moving average of GBX 38.29.

Alliance Pharma Company Profile

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.